Pyrimidine

Pyrimidine

SCHEMBL15020679

Cc1nn2c(-c3ccccc3)cc(Cl)cc2c1-c1ccc2c(c1)OCO2.c1cncnc1

nearest known ligand 0.41

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TP53 P04637 2/20 0.41
▸ NPC1 O15118 4/20 0.40
▸ NPSR1 Q6W5P4 2/20 0.40
▸ FYN P06241 3/20 0.40
▸ HPGD P15428 2/20 0.40
▸ ALDH1A1 P00352 3/20 0.39
▸ ALOX15 P16050 2/20 0.39
▸ HSD17B10 Q99714 2/20 0.39
▸ EDNRA P25101 1/20 0.39
▸ PDE5A O76074 1/20 0.39
▸ SMN1; SMN2 Q16637 5/20 0.38
▸ KMT2A Q03164 4/20 0.38
▸ KDM4E B2RXH2 3/20 0.38
▸ MEN1 O00255 3/20 0.38
▸ RAB9A P51151 3/20 0.38
▸ MAPT P10636 2/20 0.38
▸ POLB P06746 1/20 0.38
▸ FLT3 P36888 1/20 0.37
▸ USP2 O75604 1/20 0.37
▸ TSHR P16473 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15121459 0.94 TP53 (0.46) TP53NPC1NPSR1FYNHPGD
SCHEMBL256941 0.77 TP53 (0.55) TP53NPC1NPSR1FYNHPGD
Pyrimidine SCHEMBL15020697 0.77 NPC1 (0.46) TP53NPC1NPSR1HPGDALDH1A1
Pyrimidine SCHEMBL15020925 0.75 TP53 (0.41) TP53NPC1NPSR1SMN1; SMN2KMT2A
SCHEMBL10072102 0.72 PLAT (0.46) TP53NPC1FYNHPGDALDH1A1
SCHEMBL15121551 0.69 TP53 (0.49) TP53NPC1NPSR1HPGDALDH1A1
SCHEMBL15121533 0.64 MAPT (0.53) TP53NPC1NPSR1HPGDALDH1A1
SCHEMBL13516790 0.64 HPGD (0.46) TP53FYNHPGDALDH1A1ALOX15
SCHEMBL26143793 0.64 KDM4E (0.54) TP53NPC1HPGDALDH1A1HSD17B10
Pyrimidine SCHEMBL15020692 0.63 ARF6 (0.37) TP53KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8975264-B2 Compound acting as a cannabinoid receptor-1 inhibitor AMOREPACIFIC CORPORATION (KR) 2015-03-10 — — US disclosed
US-20130158025-A1 NOVEL COMPOUND ACTING AS A CANNABINOID RECEPTOR-1 INHIBITOR AMOREPACIFIC CORPORATION (KR) 2013-06-20 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130158025-A1 NOVEL COMPOUND ACTING AS A CANNABINOID RECEPTOR-1 INHIBITOR CNR1, CNR2, GPR18 TP53 4550/4885NPC1 114/4885NPSR1 33/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback